$LFVN
Lifevantage Corp

2020 Q4 Form 10-Q Financial Statement

#000084914621000031 Filed on February 02, 2021

View on sec.gov

Income Statement

Concept 2020 Q4 2019 Q4
Revenue $59.01M $61.24M
YoY Change -3.65% 5.29%
Cost Of Revenue $10.19M $10.23M
YoY Change -0.4% 4.45%
Gross Profit $48.82M $51.01M
YoY Change -4.3% 5.46%
Gross Profit Margin 82.73% 83.3%
Selling, General & Admin $16.22M $18.13M
YoY Change -10.55% -7.57%
% of Gross Profit 33.22% 35.54%
Research & Development $200.0K $300.0K
YoY Change -33.33% -40.0%
% of Gross Profit 0.41% 0.59%
Depreciation & Amortization $650.0K $710.0K
YoY Change -8.45% 61.36%
% of Gross Profit 1.33% 1.39%
Operating Expenses $43.37M $47.37M
YoY Change -8.44% -0.89%
Operating Profit $5.449M $3.646M
YoY Change 49.45% 527.54%
Interest Expense $9.000K $41.00K
YoY Change -78.05% -59.0%
% of Operating Profit 0.17% 1.12%
Other Income/Expense, Net $124.0K -$189.0K
YoY Change -165.61% 9.88%
Pretax Income $5.573M $3.457M
YoY Change 61.21% 745.23%
Income Tax $1.761M -$846.0K
% Of Pretax Income 31.6% -24.47%
Net Earnings $3.812M $4.303M
YoY Change -11.41% 419.06%
Net Earnings / Revenue 6.46% 7.03%
Basic Earnings Per Share $0.27 $0.31
Diluted Earnings Per Share $0.26 $0.30
COMMON SHARES
Basic Shares Outstanding 14.19M shares 13.90M shares
Diluted Shares Outstanding 14.44M shares 14.56M shares

Balance Sheet

Concept 2020 Q4 2019 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $19.73M $14.48M
YoY Change 36.26% -23.75%
Cash & Equivalents $19.73M $14.48M
Short-Term Investments
Other Short-Term Assets $4.220M $6.120M
YoY Change -31.05% -0.16%
Inventory $14.71M $14.22M
Prepaid Expenses
Receivables $3.269M $1.788M
Other Receivables $540.0K $1.000M
Total Short-Term Assets $42.46M $37.61M
YoY Change 12.89% -13.85%
LONG-TERM ASSETS
Property, Plant & Equipment $11.03M $7.586M
YoY Change 45.36% 29.72%
Goodwill
YoY Change
Intangibles $785.0K $917.0K
YoY Change -14.39% -12.58%
Long-Term Investments $2.210M $2.210M
YoY Change 0.0%
Other Assets $2.047M $1.548M
YoY Change 32.24% 23.35%
Total Long-Term Assets $31.97M $17.41M
YoY Change 83.66% 66.8%
TOTAL ASSETS
Total Short-Term Assets $42.46M $37.61M
Total Long-Term Assets $31.97M $17.41M
Total Assets $74.43M $55.02M
YoY Change 35.28% 1.71%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $5.155M $3.900M
YoY Change 32.18% -5.06%
Accrued Expenses $16.65M $20.69M
YoY Change -19.53% -8.0%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $484.0K
YoY Change -75.8%
Total Short-Term Liabilities $22.45M $25.25M
YoY Change -11.06% -12.23%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change -100.0%
Other Long-Term Liabilities $1.047M $387.0K
YoY Change 170.54% -79.47%
Total Long-Term Liabilities $1.047M $387.0K
YoY Change 170.54% -91.03%
TOTAL LIABILITIES
Total Short-Term Liabilities $22.45M $25.25M
Total Long-Term Liabilities $1.047M $387.0K
Total Liabilities $38.91M $25.92M
YoY Change 50.12% -21.63%
SHAREHOLDERS EQUITY
Retained Earnings -$93.04M -$96.79M
YoY Change -3.87% -5.56%
Common Stock $128.0M $125.9M
YoY Change 1.71% 1.91%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $35.52M $29.10M
YoY Change
Total Liabilities & Shareholders Equity $74.43M $55.02M
YoY Change 35.28% 1.71%

Cashflow Statement

Concept 2020 Q4 2019 Q4
OPERATING ACTIVITIES
Net Income $3.812M $4.303M
YoY Change -11.41% 419.06%
Depreciation, Depletion And Amortization $650.0K $710.0K
YoY Change -8.45% 61.36%
Cash From Operating Activities $5.890M $9.230M
YoY Change -36.19% 101.97%
INVESTING ACTIVITIES
Capital Expenditures -$570.0K -$880.0K
YoY Change -35.23% 388.89%
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change -100.0%
Cash From Investing Activities -$570.0K -$880.0K
YoY Change -35.23% 12.82%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $4.000M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -3.670M -6.820M
YoY Change -46.19% 242.71%
NET CHANGE
Cash From Operating Activities 5.890M 9.230M
Cash From Investing Activities -570.0K -880.0K
Cash From Financing Activities -3.670M -6.820M
Net Change In Cash 1.650M 1.530M
YoY Change 7.84% -15.0%
FREE CASH FLOW
Cash From Operating Activities $5.890M $9.230M
Capital Expenditures -$570.0K -$880.0K
Free Cash Flow $6.460M $10.11M
YoY Change -36.1% 112.84%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Entity Central Index Key
EntityCentralIndexKey
0000849146
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--06-30
CY2019 us-gaap Accounting Standards Update Extensible List
AccountingStandardsUpdateExtensibleList
us-gaap:AccountingStandardsUpdate201602Member
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 Segment
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2020-12-31
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-35647
dei Entity Registrant Name
EntityRegistrantName
LIFEVANTAGE CORP
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
90-0224471
dei Entity Address Address Line1
EntityAddressAddressLine1
3300 Triumph Blvd
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 700
dei Entity Address City Or Town
EntityAddressCityOrTown
Lehi
dei Entity Address State Or Province
EntityAddressStateOrProvince
UT
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
84043
dei City Area Code
CityAreaCode
801
dei Local Phone Number
LocalPhoneNumber
432-9000
dei Security12b Title
Security12bTitle
Common Stock, par value $0.0001
dei Trading Symbol
TradingSymbol
LFVN
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2021Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
14166584 shares
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
19726000 USD
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
22138000 USD
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
3269000 USD
CY2020Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
2610000 USD
CY2020Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
536000 USD
CY2020Q2 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
0 USD
CY2020Q4 us-gaap Inventory Net
InventoryNet
14712000 USD
CY2020Q2 us-gaap Inventory Net
InventoryNet
13888000 USD
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
4216000 USD
CY2020Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
5232000 USD
CY2020Q4 us-gaap Assets Current
AssetsCurrent
42459000 USD
CY2020Q2 us-gaap Assets Current
AssetsCurrent
43868000 USD
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
11027000 USD
CY2020Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
7170000 USD
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
14037000 USD
CY2020Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
956000 USD
CY2020Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
785000 USD
CY2020Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
851000 USD
CY2020Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
1866000 USD
CY2020Q2 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
2164000 USD
CY2020Q4 us-gaap Long Term Investments
LongTermInvestments
2205000 USD
CY2020Q2 us-gaap Long Term Investments
LongTermInvestments
2205000 USD
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2047000 USD
CY2020Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1663000 USD
CY2020Q4 us-gaap Assets
Assets
74426000 USD
CY2020Q2 us-gaap Assets
Assets
58877000 USD
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
5155000 USD
CY2020Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
3521000 USD
CY2020Q4 us-gaap Accrued Sales Commission Current
AccruedSalesCommissionCurrent
8039000 USD
CY2020Q2 us-gaap Accrued Sales Commission Current
AccruedSalesCommissionCurrent
9219000 USD
CY2020Q4 us-gaap Taxes Payable Current And Noncurrent
TaxesPayableCurrentAndNoncurrent
651000 USD
CY2020Q2 us-gaap Taxes Payable Current And Noncurrent
TaxesPayableCurrentAndNoncurrent
784000 USD
CY2020Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2049000 USD
CY2020Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1184000 USD
CY2020Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
6560000 USD
CY2020Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
10311000 USD
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
22454000 USD
CY2020Q2 us-gaap Liabilities Current
LiabilitiesCurrent
25019000 USD
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
15409000 USD
CY2020Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
0 USD
CY2020Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1047000 USD
CY2020Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
604000 USD
CY2020Q4 us-gaap Liabilities
Liabilities
38910000 USD
CY2020Q2 us-gaap Liabilities
Liabilities
25623000 USD
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2020Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2020Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2020Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2020Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2020Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2020Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
40000000 shares
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
40000000 shares
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
14151000 shares
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
14151000 shares
CY2020Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
14313000 shares
CY2020Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
14313000 shares
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
1000 USD
CY2020Q2 us-gaap Common Stock Value
CommonStockValue
1000 USD
CY2020Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
128011000 USD
CY2020Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
126416000 USD
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-93044000 USD
CY2020Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-93307000 USD
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
548000 USD
CY2020Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
144000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
35516000 USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
33254000 USD
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
74426000 USD
CY2020Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
58877000 USD
CY2020Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
59007000 USD
CY2019Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
61242000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
113835000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
117470000 USD
CY2020Q4 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
10189000 USD
CY2019Q4 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
10230000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
19587000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
19421000 USD
CY2020Q4 us-gaap Gross Profit
GrossProfit
48818000 USD
CY2019Q4 us-gaap Gross Profit
GrossProfit
51012000 USD
us-gaap Gross Profit
GrossProfit
94248000 USD
us-gaap Gross Profit
GrossProfit
98049000 USD
CY2020Q4 lfvn Commission And Incentives
CommissionAndIncentives
27151000 USD
CY2019Q4 lfvn Commission And Incentives
CommissionAndIncentives
29235000 USD
lfvn Commission And Incentives
CommissionAndIncentives
52785000 USD
lfvn Commission And Incentives
CommissionAndIncentives
56009000 USD
CY2020Q4 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
16218000 USD
CY2019Q4 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
18131000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
32517000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
35817000 USD
CY2020Q4 us-gaap Operating Expenses
OperatingExpenses
43369000 USD
CY2019Q4 us-gaap Operating Expenses
OperatingExpenses
47366000 USD
us-gaap Operating Expenses
OperatingExpenses
85302000 USD
us-gaap Operating Expenses
OperatingExpenses
91826000 USD
CY2020Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
5449000 USD
CY2019Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
3646000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
8946000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
6223000 USD
CY2020Q4 us-gaap Interest Expense
InterestExpense
9000 USD
CY2019Q4 us-gaap Interest Expense
InterestExpense
41000 USD
us-gaap Interest Expense
InterestExpense
15000 USD
us-gaap Interest Expense
InterestExpense
89000 USD
CY2020Q4 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
133000 USD
CY2019Q4 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-148000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-8000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-228000 USD
CY2020Q4 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
124000 USD
CY2019Q4 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-189000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-23000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-317000 USD
CY2020Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
5573000 USD
CY2019Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
3457000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
8923000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
5906000 USD
CY2020Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1761000 USD
CY2019Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-846000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2660000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-158000 USD
CY2020Q4 us-gaap Net Income Loss
NetIncomeLoss
3812000 USD
CY2019Q4 us-gaap Net Income Loss
NetIncomeLoss
4303000 USD
us-gaap Net Income Loss
NetIncomeLoss
6263000 USD
us-gaap Net Income Loss
NetIncomeLoss
6064000 USD
CY2020Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.27
CY2019Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.31
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.44
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.44
CY2020Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.26
CY2019Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.30
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.43
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.42
CY2020Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
14193000 shares
CY2019Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13902000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
14225000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13908000 shares
CY2020Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
14439000 shares
CY2019Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
14562000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
14547000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
14515000 shares
CY2020Q4 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
244000 USD
CY2019Q4 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-14000 USD
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
404000 USD
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-30000 USD
CY2020Q4 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
244000 USD
CY2019Q4 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-14000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
404000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-30000 USD
CY2020Q4 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
4056000 USD
CY2019Q4 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
4289000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
6667000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
6034000 USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
33254000 USD
CY2020Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
520000 USD
CY2020Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
11000 USD
CY2020Q3 us-gaap Stock Issued During Period Shares Employee Stock Purchase Plans
StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
23000 shares
CY2020Q3 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
246000 USD
CY2020Q3 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
506000 USD
CY2020Q3 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
2000000 USD
CY2020Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
160000 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
2451000 USD
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
34136000 USD
CY2020Q4 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
999000 USD
CY2020Q4 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
991000 USD
CY2020Q4 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
666000 USD
CY2020Q4 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
4000000 USD
CY2020Q4 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
244000 USD
CY2020Q4 us-gaap Net Income Loss
NetIncomeLoss
3812000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
35516000 USD
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
27199000 USD
CY2019Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1276000 USD
CY2019Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
11000 USD
CY2019Q3 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
61000 USD
CY2019Q3 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
1393000 USD
CY2019Q3 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
339000 USD
CY2019Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-16000 USD
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
1761000 USD
CY2019Q3 us-gaap Stockholders Equity
StockholdersEquity
29624000 USD
CY2019Q4 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1503000 USD
CY2019Q4 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
54000 USD
CY2019Q4 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
4360000 USD
CY2019Q4 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
2012000 USD
CY2019Q4 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-14000 USD
CY2019Q4 us-gaap Net Income Loss
NetIncomeLoss
4303000 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
29098000 USD
us-gaap Net Income Loss
NetIncomeLoss
6263000 USD
us-gaap Net Income Loss
NetIncomeLoss
6064000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1782000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1245000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
1447000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
2918000 USD
lfvn Operating Lease Right Of Use Asset Amortization
OperatingLeaseRightOfUseAssetAmortization
1676000 USD
lfvn Operating Lease Right Of Use Asset Amortization
OperatingLeaseRightOfUseAssetAmortization
1148000 USD
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
0 USD
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
4000 USD
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
0 USD
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
26000 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
298000 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-486000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
553000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-275000 USD
us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
534000 USD
us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
-230000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
442000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
452000 USD
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-1062000 USD
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
1000000 USD
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
165000 USD
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
279000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
236000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1268000 USD
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-133000 USD
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-422000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-4759000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-805000 USD
lfvn Increase Decrease In Lease Liabilities
IncreaseDecreaseInLeaseLiabilities
-1375000 USD
lfvn Increase Decrease In Lease Liabilities
IncreaseDecreaseInLeaseLiabilities
-1328000 USD
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
37000 USD
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-105000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
4840000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
5765000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1532000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1633000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1532000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1633000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
6000000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
3405000 USD
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
0 USD
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
1000000 USD
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
1172000 USD
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
4421000 USD
lfvn Proceeds From Issuance Of Common Stock Under Employee Stock Purchase Plan
ProceedsFromIssuanceOfCommonStockUnderEmployeeStockPurchasePlan
246000 USD
lfvn Proceeds From Issuance Of Common Stock Under Employee Stock Purchase Plan
ProceedsFromIssuanceOfCommonStockUnderEmployeeStockPurchasePlan
339000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1002000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
65000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-5924000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-8422000 USD
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
204000 USD
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-55000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-2412000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-4345000 USD
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
22138000 USD
CY2019Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
18824000 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
19726000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
14479000 USD
lfvn Increase Decrease In Property And Equipment And Lease Liabilities From Lease Incentives
IncreaseDecreaseInPropertyAndEquipmentAndLeaseLiabilitiesFromLeaseIncentives
2687000 USD
lfvn Increase Decrease In Property And Equipment And Lease Liabilities From Lease Incentives
IncreaseDecreaseInPropertyAndEquipmentAndLeaseLiabilitiesFromLeaseIncentives
0 USD
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
1349000 USD
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
0 USD
us-gaap Interest Paid Net
InterestPaidNet
15000 USD
us-gaap Interest Paid Net
InterestPaidNet
36000 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
2618000 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
654000 USD
us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company prepares the condensed consolidated financial statements and related disclosures in conformity with accounting principles generally accepted in the United States of America (GAAP). In preparing these statements, the Company is required to use estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ materially from those estimates and assumptions. On an ongoing basis, the Company reviews its estimates, including, but not limited to, those related to inventory valuation and obsolescence, sales returns, income taxes and tax valuation reserves, transfer pricing methodology and positions, impairment of assets, share-based compensation, and loss contingencies.</span></div>
CY2020Q4 us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
300000 USD
CY2019Q4 us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
100000 USD
us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
400000 USD
us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
12000 USD
CY2020Q4 us-gaap Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
-200000 USD
CY2019Q4 us-gaap Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
-200000 USD
us-gaap Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
-400000 USD
us-gaap Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
-300000 USD
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
Concentration of Credit RiskAccounting guidance for financial instruments requires disclosure of significant concentrations of credit risk regardless of the degree of such risk. Financial instruments with significant credit risk include cash and investments.
CY2019Q4 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
0 USD
CY2020Q2 us-gaap Inventory Raw Materials And Supplies Net Of Reserves
InventoryRawMaterialsAndSuppliesNetOfReserves
3724000 USD
CY2020Q2 lfvn Inventory Finished Goods Percent Of Total Inventory
InventoryFinishedGoodsPercentOfTotalInventory
0.732
CY2020Q4 us-gaap Inventory Raw Materials And Supplies Net Of Reserves
InventoryRawMaterialsAndSuppliesNetOfReserves
4063000 USD
CY2020Q4 lfvn Raw Materials Percent Of Total Inventory
RawMaterialsPercentOfTotalInventory
0.276
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
0 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
0 USD
CY2020Q4 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
0 USD
CY2020Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
10649000 USD
CY2020Q4 lfvn Inventory Finished Goods Percent Of Total Inventory
InventoryFinishedGoodsPercentOfTotalInventory
0.724
CY2020Q2 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
10164000 USD
CY2020Q2 lfvn Raw Materials Percent Of Total Inventory
RawMaterialsPercentOfTotalInventory
0.268
CY2020Q4 us-gaap Inventory Net
InventoryNet
14712000 USD
CY2020Q4 lfvn Inventory Percent Of Total Inventory
InventoryPercentOfTotalInventory
1.000
CY2020Q2 us-gaap Inventory Net
InventoryNet
13888000 USD
CY2020Q2 lfvn Inventory Percent Of Total Inventory
InventoryPercentOfTotalInventory
1.000
CY2020Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
300000 USD
CY2020Q2 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
200000 USD
lfvn Money Back Guarantee Period
MoneyBackGuaranteePeriod
P30D
CY2020Q4 lfvn Handling And Restocking Fee Percentage
HandlingAndRestockingFeePercentage
0.10
CY2020Q4 lfvn Return Liability Reserve
ReturnLiabilityReserve
200000 USD
CY2020Q2 lfvn Return Liability Reserve
ReturnLiabilityReserve
300000 USD
CY2020Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
200000 USD
CY2019Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
300000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
400000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
500000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2700000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-200000 USD
CY2020Q4 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
45000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
100000 shares
CY2019Q4 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
100000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
200000 shares
CY2020Q4 us-gaap Net Income Loss
NetIncomeLoss
3812000 USD
CY2019Q4 us-gaap Net Income Loss
NetIncomeLoss
4303000 USD
us-gaap Net Income Loss
NetIncomeLoss
6263000 USD
us-gaap Net Income Loss
NetIncomeLoss
6064000 USD
CY2020Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
14193000 shares
CY2019Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13902000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
14225000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13908000 shares
CY2020Q4 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
246000 shares
CY2019Q4 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
660000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
322000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
607000 shares
CY2020Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
14439000 shares
CY2019Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
14562000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
14547000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
14515000 shares
CY2020Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.27
CY2019Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.31
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.44
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.44
CY2020Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.26
CY2019Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.30
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.43
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.42
lfvn Number Of Geographic Segments
NumberOfGeographicSegments
2 region
lfvn Number Of Geographic Segments
NumberOfGeographicSegments
2 region
CY2020Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
59007000 USD
CY2019Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
61242000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
113835000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
117470000 USD
CY2020Q4 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
2200000 USD
CY2020Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P9Y2M1D
CY2020Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0334
CY2020Q4 us-gaap Operating Lease Expense
OperatingLeaseExpense
800000 USD
CY2019Q4 us-gaap Operating Lease Expense
OperatingLeaseExpense
700000 USD
us-gaap Operating Lease Expense
OperatingLeaseExpense
2000000.0 USD
us-gaap Operating Lease Expense
OperatingLeaseExpense
1300000 USD
CY2020Q4 us-gaap Operating Lease Payments
OperatingLeasePayments
776000 USD
CY2019Q4 us-gaap Operating Lease Payments
OperatingLeasePayments
720000 USD
us-gaap Operating Lease Payments
OperatingLeasePayments
1392000 USD
us-gaap Operating Lease Payments
OperatingLeasePayments
1440000 USD
CY2020Q4 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
0 USD
CY2019Q4 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
0 USD
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
14682000 USD
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
0 USD
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
1225000 USD
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
2431000 USD
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
3043000 USD
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
1726000 USD
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
1606000 USD
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
10601000 USD
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
20632000 USD
CY2020Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
3174000 USD
CY2020Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
17458000 USD
CY2017Q4 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
5000000 USD
CY2017Q4 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
5000000 USD
CY2019Q1 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
15000000 USD
CY2019Q1 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
15000000 USD
CY2020Q3 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
35000000 USD
us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
500000 shares
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
6000000.0 USD
CY2020Q4 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
17400000 USD
CY2020Q4 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
1000000.0 USD
us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
1500000 USD
CY2020Q4 lfvn Sharebased Compensation Arrangementby Sharebased Payment Award Increase Decreaseof Sharebased Liabilities
SharebasedCompensationArrangementbySharebasedPaymentAwardIncreaseDecreaseofSharebasedLiabilities
17000 USD
lfvn Sharebased Compensation Arrangementby Sharebased Payment Award Increase Decreaseof Sharebased Liabilities
SharebasedCompensationArrangementbySharebasedPaymentAwardIncreaseDecreaseofSharebasedLiabilities
100000 USD
CY2019Q4 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
1400000 USD
us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
2700000 USD
CY2019Q4 lfvn Sharebased Compensation Arrangementby Sharebased Payment Award Increase Decreaseof Sharebased Liabilities
SharebasedCompensationArrangementbySharebasedPaymentAwardIncreaseDecreaseofSharebasedLiabilities
100000 USD
lfvn Sharebased Compensation Arrangementby Sharebased Payment Award Increase Decreaseof Sharebased Liabilities
SharebasedCompensationArrangementbySharebasedPaymentAwardIncreaseDecreaseofSharebasedLiabilities
200000 USD
us-gaap Loss Contingency Disclosures
LossContingencyDisclosures
Commitments and Contingencies<div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingencies</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for contingent liabilities in accordance with ASC 450, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. This guidance requires management to assess potential contingent liabilities that may exist as of the date of the financial statements to determine the probability and amount of loss that may have occurred, which inherently involves an exercise of judgment. If the assessment of a contingency indicates that it is probable that a material loss has been incurred and the amount of the liability can be estimated, then the estimated liability would be accrued in the Company’s financial statements. If the assessment indicates that a potential material loss contingency is not probable but is reasonably possible, or is probable but cannot be estimated, then the nature of the contingent liability, and an estimate of the range of possible losses, if determinable and material, would be disclosed. For loss contingencies considered remote, no accrual or disclosures are generally made. Management has assessed potential contingent liabilities as of December 31, 2020, and based on the assessment, there are no probable loss contingencies requiring accrual or disclosures within its financial statements.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Legal Accruals</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to commitments and obligations in the ordinary course of business, from time to time, the Company is subject to various claims, pending and potential legal actions, investigations relating to governmental laws and regulations and other matters arising out of the normal conduct of its business. Management assesses contingencies to determine the degree of probability and range of possible loss for potential accrual in the consolidated financial statements. An estimated loss contingency is accrued in the consolidated financial statements if it is probable that a liability has been incurred and the amount of the loss can be reasonably estimated. Because evaluating legal claims and litigation results are inherently unpredictable and unfavorable results could occur, assessing contingencies is highly subjective and requires judgments about future events. When evaluating contingencies, management may be unable to provide a meaningful estimate due to a number of factors, including the procedural status of the matter in question, the presence of complex or novel legal theories, and/or the ongoing discovery and development of information important to the matters. In addition, damage amounts claimed or asserted against the Company may be unsupported, exaggerated or unrelated to possible outcomes, and as such are not meaningful indicators of a potential liability. Management regularly reviews contingencies to determine the adequacy of financial statement accruals and related disclosures. The amount of ultimate loss may differ from these estimates. It is possible that cash flows or results of operations could be materially affected in any particular period by the unfavorable resolution of one or more of these contingencies. Whether any losses finally determined in any claim, action, investigation or proceeding could reasonably have a material effect on the Company's business, financial condition, results of operations or cash flows will depend on a number of variables, including: the timing and amount of such losses; the structure and type of any remedies; the significance of the impact of any such losses, damages or remedies may have on the consolidated financial statements; and the unique facts and circumstances of the particular matter that may give rise to additional factors.</span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Class Action Lawsuit (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Smith v. LifeVantage Corp</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">.): </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> On January 24, 2018, a purported class action was filed in the United States District Court for the District of Connecticut, entitled Smith v. LifeVantage Corp., Case No. 3:18-cv-a35 (D. Connecticut filed Jan. 24, 2018). In this action, Plaintiffs alleged that the Company, its Chief Executive Officer, Chief Sales Officer and Chief Marketing Officer operated a pyramid scheme in violation of a variety of federal and state statutes, including RICO and the Connecticut Unfair Trade Practices Act. On April 16, 2018, the Company filed motions with the court to dismiss the complaint against LifeVantage, dismiss the complaint against the Company's executives, transfer the venue of the case from the State of Connecticut to the State of Utah, and contest class certification. On July 23, 2018, the parties filed a stipulation with the Court agreeing to transfer the case to the Federal District Court for Utah. On September 20, 2018, Plaintiffs filed an amended complaint in Utah. As per the parties stipulated agreement, Plaintiff's amended complaint dropped the RICO and </span></div>Connecticut state law claims and removed the Company's Chief Sales Officer and Chief Marketing Officer as individual defendants (the Chief Executive Officer remains a defendant in the case). The Plaintiffs' amended complaint added an antitrust claim, alleging that the Company fraudulently obtained patents for its products and is attempting to use those patents in an anti-competitive manner. The Company filed a Motion to Dismiss the amended complaint on November 5, 2018, Plaintiffs filed a response to the Company’s Motion to Dismiss on December 17, 2018, and the Company filed a reply brief on January 10, 2019. The Court ruled on the motion on December 5, 2019, dismissing three of the Plaintiff's four claims, including the antitrust claim, unjust enrichment claim, and the securities claim for the sale of unregistered securities. On December 19, 2019, Plaintiffs filed a second amended complaint which included three causes of action, including a 10(b)(5) securities fraud claim, and renewed claims relating to the sale of unregistered securities and unjust enrichment. LifeVantage filed a Motion to Dismiss the Second Amended Complaint on January 28, 2020, and with the Motion fully briefed by the parties as of March 17, 2020, the Court decided the matter on the parties’ briefs only on November 25, 2020. In its decision, the Court dismissed with prejudice the Plaintiffs’ Section 12(1) claim (sale of an unregistered security), because the Court concluded the claim is time barred. The Court also dismissed the Plaintiffs’ claim for unjust enrichment against LifeVantage without prejudice, but the Plaintiffs subsequently agreed to drop this claim going forward. The court found that the Plaintiffs had sufficiently pled their claim under Section 12(2) (offer to sell a security that misstates or omits a material fact by means of a prospectus or oral communication). LifeVantage filed its Answer to the Second Amended Complaint on December 23, 2020, responding to the Plaintiffs’ remaining securities claims. As reported previously, on May 6, 2020, the Court issued a formal scheduling order to confirm the parties’ agreement on a schedule for discovery and other litigation matters, and initial discovery has begun and will continue per the order. The Company has not established a loss contingency accrual for this lawsuit as it believes liability is not probable or estimable, and the Company plans to vigorously defend against this lawsuit. Nonetheless, an unfavorable resolution of this matter could have a material adverse effect on the Company's business, results of operations or financial condition.<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Matters.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span>In addition to the matters described above, the Company also may become involved in other litigation and regulatory matters incidental to its business and the matters disclosed in this quarterly report on Form 10-Q, including, but not limited to, product liability claims, regulatory actions, employment matters and commercial disputes. The Company intends to defend itself in any such matters and does not currently believe that the outcome of any such matters will have a material adverse effect on the Company's business, financial condition, results of operations and cash flows.
CY2019Q4 us-gaap Loss Contingency Claims Dismissed Number
LossContingencyClaimsDismissedNumber
3 claim
CY2019Q4 us-gaap Loss Contingency Pending Claims Number
LossContingencyPendingClaimsNumber
4 claim
lfvn Members Of Board Of Directors Serving On Related Party Board Of Directors
MembersOfBoardOfDirectorsServingOnRelatedPartyBoardOfDirectors
2 member

Files In Submission

Name View Source Status
0000849146-21-000031-index-headers.html Edgar Link pending
0000849146-21-000031-index.html Edgar Link pending
0000849146-21-000031.txt Edgar Link pending
0000849146-21-000031-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
lfvn-20201231.htm Edgar Link pending
lfvn-20201231.xsd Edgar Link pending
lfvn-20201231_cal.xml Edgar Link unprocessable
lfvn-20201231_def.xml Edgar Link unprocessable
lfvn-20201231_htm.xml Edgar Link completed
lfvn-20201231_lab.xml Edgar Link unprocessable
lfvn-20201231_pre.xml Edgar Link unprocessable
lfvn_123120xex311.htm Edgar Link pending
lfvn_123120xex312.htm Edgar Link pending
lfvn_123120xex321.htm Edgar Link pending
lfvn_123120xex322.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
R9999.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending